HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $280

Benzinga · 3d ago
HC Wainwright & Co. analyst Robert Burns maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $195 to $280.